Clinical trial
Phase II Study of Multimodality Therapy in Mantle Cell Lymphoma
NCT00004231 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Multimodality Therapy in Mantle Cell Lymphoma
- Lead sponsor
- Northwestern University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 1999
- Completion date
- August 31, 2006
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.